Ingredient guide
D-mannose is a sugar related to glucose, sold as a urinary tract supplement. Smaller and older trials were positive, but the largest recent randomised trial in 598 women found no reduction in UTI rates. The evidence is mixed.
Mixed evidenceD-mannose is a simple sugar with a chemical structure similar to glucose. It is found in small amounts in fruits like cranberries, apples, and oranges. Unlike glucose, most swallowed D-mannose is not processed for energy. Instead, it is absorbed and excreted largely unchanged in urine, which is why it ends up in the bladder.
The leading theory is that D-mannose in urine attaches to the sticky parts (called fimbriae) of E. coli bacteria, which cause most uncomplicated urinary tract infections. Coated in D-mannose, the bacteria cannot grip the bladder wall and are flushed out before they can take hold. The mechanism is plausible and well-described in laboratory studies.
Smaller and earlier randomised trials in women with recurrent urinary tract infections were positive, often reporting fewer infections with D-mannose at 2 g per day. Several review articles cited these as encouraging signs of a low-risk option for prevention.
Then a much larger and rigorous 2024 randomised trial in primary care enrolled 598 women with recurrent UTIs and found that 2 g of D-mannose daily for six months did not significantly lower the proportion of women who got another UTI. The authors concluded D-mannose should not be recommended for prophylaxis in this group. We grade the overall evidence as mixed and now leaning negative for routine prevention.
Trials use 2 g per day in 1 or 2 doses, dissolved in a full glass of water. Despite the recent negative trial, some people still try it given its safety profile. Never use D-mannose alone for suspected urinary symptoms, since a real case needs medical assessment and possibly antibiotics.
Trials commonly use 2 g per day in 1 or 2 doses, dissolved in water. Some people use higher doses at the first sign of urinary symptoms. Take it on its own with a full glass of water. Ask your healthcare provider before regular use if you have diabetes.
Earlier small trials said yes, but a large 2024 trial found no benefit in primary care. The evidence is mixed and now leans negative for routine prevention.
Most studies show only a small effect on blood sugar at typical doses. Higher doses may raise it slightly, so people with diabetes should check with a doctor first.
It is generally well tolerated for at least six months in trials. Long-term safety beyond that is not well studied.
No. Both target bacterial adhesion in the bladder but through different compounds. They are sometimes combined in urinary products.
